Drugs / NGX267
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00637793 | Feb → Nov 2008 | Sjogren syndrome | TorreyPines Therapeutics | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NGX267 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00637793 ↗ |
| Known as | AF-267B | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297408 ↗ |
| Modality | Small molecule | — CHEMBL4297408 ↗ |
| Route | Oral | “NGX267 Oral Capsules” NCT00637793 ↗ |